← Back to Search

Other

Vagal Nerve Stimulation for POTS

N/A
Recruiting
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-80 years old, female or male
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minute
Awards & highlights

Study Summary

This trial will test if an autoimmune reaction is the cause of symptoms in some patients with POTS, and if electrical stimulation of the vagus nerve can help.

Who is the study for?
This trial is for adults aged 18-80 with Postural Tachycardia Syndrome (POTS), characterized by a rapid heartbeat upon standing, without other causes of orthostatic tachycardia. Healthy controls must be non-smoking and not on chronic medications. Excluded are those with recent heart attacks, significant immune or blood disorders, pregnancy, pacemakers or cochlear implants, severe hypertension, history of vagotomy.Check my eligibility
What is being tested?
The study aims to see if stimulating the vagus nerve can improve symptoms in POTS patients by potentially reducing autoimmune reactions and inflammation. Participants will receive either actual vagal stimulation or sham (fake) stimulation to compare effects.See study design
What are the potential side effects?
While specific side effects aren't listed here, generally speaking, vagal stimulation might cause discomfort at the site of stimulation, changes in voice tone due to laryngeal muscle activation and possible temporary changes in heart rate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate variability

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Vagal stimulationActive Control1 Intervention
Vagal stimulation will be given at 20 Hz for 1 hour daily with the bipolar electrode attached to the tragus for 2 months.
Group II: Sham stimulationPlacebo Group1 Intervention
Sham stimulation will be given at 20 Hz for 1 hour daily with the bipolar electrode attached to the earlobe for 2 months.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,843 Total Patients Enrolled
2 Trials studying Postural Orthostatic Tachycardia Syndrome
63 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,514 Total Patients Enrolled
10 Trials studying Postural Orthostatic Tachycardia Syndrome
410 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Stavros Stavrakis, MDStudy DirectorUniversity of Oklahoma
5 Previous Clinical Trials
298 Total Patients Enrolled
1 Trials studying Postural Orthostatic Tachycardia Syndrome
5 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome

Media Library

Vagal stimulation (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05043051 — N/A
Postural Orthostatic Tachycardia Syndrome Research Study Groups: Vagal stimulation, Sham stimulation
Postural Orthostatic Tachycardia Syndrome Clinical Trial 2023: Vagal stimulation Highlights & Side Effects. Trial Name: NCT05043051 — N/A
Vagal stimulation (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05043051 — N/A
Postural Orthostatic Tachycardia Syndrome Patient Testimony for trial: Trial Name: NCT05043051 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial enlisting new participants at the present?

"As per the information on clinicaltrials.gov, this clinical trial is actively accepting participants. The initial posting date was January 14th 2022 with a most recent update of March 2nd 2022."

Answered by AI

Does the eligibility criteria for this trial encompass seniors aged 85 or older?

"The parameters of this clinical trial are set to allow patients aged between 18 and 80. However, there is a total of 386 medical studies available for those under the age of majority and 1071 resources aimed at seniors above 65 years old."

Answered by AI

Who has the credentials to join this medical study?

"To be a viable candidate for this trial, applicants must suffer from postural orthostatic tachycardia syndrome and have an age between 18 and 80. Currently, the enrolment goal is approximately 80 participants."

Answered by AI

How many individuals are participating in this clinical trial?

"Indeed, according to clinicaltrials.gov, the trial that was posted on January 14th 2022 is currently enrolling participants. 80 subjects are needed from a single institution for this research effort."

Answered by AI

Who else is applying?

What state do they live in?
Texas
Florida
How old are they?
18 - 65
What site did they apply to?
Oklahoma Clinical and Translational Science Institute
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I’m suffering with POTS and there are no health care providers that are experts in this field I. Miami. Looking for a study as well.
PatientReceived 1 prior treatment
I have tried medication that doesn’t work. I would love to reduce my pot’s symptoms and help doctors learn more about the disorder and help find ways to treat it.
PatientReceived 1 prior treatment
~22 spots leftby Feb 2025